ArticleBritish journal of cancer2018

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.

Jeffrey R Infante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.